An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia
Latest Information Update: 16 Aug 2024
At a glance
- Drugs CARDIX-101 (Primary)
- Indications Bradycardia
- Focus Adverse reactions; Therapeutic Use
- Sponsors CARDIX Therapeutics
- 13 Aug 2024 Status changed to completed.
- 18 Jul 2022 Planned End Date changed from 20 Dec 2023 to 20 Dec 2024.
- 18 Jul 2022 Planned primary completion date changed from 20 Dec 2023 to 20 Dec 2024.